Catinazzo Thomas bought RLAY
June 22, 2026 · Form 4 insider transaction
Catinazzo Thomas bought 56,323 shares of Relay Therapeutics, Inc. at $5.04 per share, a transaction worth $283.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
56,323
Price
$5.04
Total value
$283.9K
InsiderCatinazzo Thomas
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after233,784
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.; Includes 9,807 shares underlying restricted stock units.